Solvent-detergent-treated fresh frozen plasma: A superior alternative to standard fresh frozen plasma?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 6, 2000, Pages 712-717

  Sharma, Ajeet D ^a,b   Sreeram, Gautam ^a,b   Erb, Thomas ^a,b   Grocott, Hilary P ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Durham Veterans Affairs   (United States)

Author keywords

Adverse effects; Clinical use; Coagulation factor deficiency; Fresh frozen plasma; Solvent detergent fresh frozen plasma; Viral inactivation

Indexed keywords

DETERGENT; FRESH FROZEN PLASMA; METHYLENE BLUE; SOLVENT; WARFARIN;

BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD TRANSFUSION; CLINICAL TRIAL; HUMAN; PASTEURIZATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INACTIVATION;

EID: 0033668693     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2000.18578     Document Type: Article

References (48)

1. AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: Prevalence, seroconversion rate, and clinical correlations
2. Prevalence of hepatitis B virus antibody in a cohort of hemophilia patients
3. Sterilization of hepatitis and HTLV-III viruses by exposure to tri (n-butyl) phosphate and sodium cholate
4. The use of tri (n-butyl) phosphate (TNBP) detergent mixtures to inactivate hepatitis viruses and immunodeficiency virus in plasma and its subsequent fractionation
5. Inactivation of viruses in labile blood derivatives: Disruption of lipid-enveloped viruses by tri (n-butyl) phosphate detergent combinations
6. Tri (n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives
7. Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma
8. Blood protein derivative viral safety: Observations and analysis
9. Current status of solvent detergent-treated plasma
10. Inactivation of hepatitis B and Hutchison strain non-A, non-B, hepatitis viruses by exposing to Tween 80 and ether
11. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma
12. The economic impact of inappropriate blood transfusion in coronary artery bypass graft surgery
13. The risk of transfusion-transmitted viral infections
14. Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction
15. Clinical studies with solvent-detergent-treated products
16. Evaluation of solvent/ detergent-treated plasma in the management of patients with hereditary and acquired coagulation disorders
17. Prospective study on efficacy and tolerability of solvent/detergent-treated plasma in intensive care unit patients
18. The use of Octaplas in patients undergoing open heart surgery
19. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
20. Solvent/detergent-treatment plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura
21. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation
22. Clinical evaluation of viral safety of coagulation factor VIII and factor IX concentrates
23. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors
24. Hemovigilance: Clinical tolerance of solvent-detergent-treated plasma
25. Virus inactivation of fresh plasma
26. Clinical significance of white cells antibodies in febrile nonhemolytic transfusion reactions
27. Frequency and causes of refractoriness in multiply transfused patients
28. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant
29. The association between perioperative blood transfusion and survival of patients with colorectal cancer
30. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery
31. Transfusion-associated graft-versus-host disease
32. Leukocyte-depleted reperfusion of transplanted hearts prevents ultrastructural evidence of reperfusion
33. Reproduction of transfusion-related acute lung injury in an ex vivo lung model
34. Detection of hepatis A virus in a factor VIII preparation by antigen capture/PCR
35. Transmission of human parvovirus B19 by coagulation factor concentrates
36. Outbreak of hepatitis A among Italian patients with hemophilia
37. Acute hepatitis A in hemophiliacs
38. Clotting factors and hepatitis A
39. Hepatitis A virus (HAV) and parvovirus B19 in donor blood
40. In vitro characterization of solvent/detergent-treated human plasma and of Quarantine fresh frozen plasma
41. Virally inactivated fresh frozen plasma
42. Inactivation of viruses in fresh-frozen plasma
43. A pasteurized therapeutic plasma
44. Safety and cost-effectiveness of solvent/detergent plasma
45. Safety of the blood supply in the United States: Opportunities and controversies
46. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
47. Human herpes virus 8 and Kaposi's sarcoma - Some answers, more questions